The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Blood–Brain Barrier Disruption in Humans Is Independently Associated With Increased Matrix Metalloproteinase-9
Open accessAbstract
Background and Purpose—Matrix metalloproteinases (MMP) may play a role in blood–brain barrier (BBB) disruption after ischemic stroke. We hypothesized that plasma concentrations of MMP-9 are associated with a marker of BBB disruption in patients evaluated for acute stroke. Methods—Patients underwent MRI on presentation and ≈24 hours later. The MRI marker, termed hyperintense acute reperfusion injury marker (HARM), is gadolinium enhancement of cerebrospinal fluid on fluid-attenuated inversion recovery MRI. Plasma MMP-9 and tissue inhibitor of matrix metalloproteinase-1 were measured by enzyme-linked immunosorbent assay. Logistic regression models tested for predictors of HARM on 24-hour follow-up scans separately for MMP-9 and the ratio of MMP-9 to TIMP-1. Results—For the 41 patients enrolled, diagnoses were: acute ischemic cerebrovascular syndrome, 33 (80.6%); intracerebral hemorrhage, 6 (14.6%); stroke mimic, 1 (2.4%); and no stroke, 1 (2.4%). HARM was present in 17 (41.5%) patients. In model 1, HARM was associated with baseline plasma MMP-9 concentration (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.001–1.019;P=0.033). In model 2, HARM was associated with the ratio of MMP-9 to tissue inhibitor of matrix metalloproteinase-1 (OR, 4.94; 95% CI, 1.27–19.14;P=0.021). Conclusions—Baseline MMP-9 was a significant predictor of HARM at 24-hour follow-up, supporting the hypothesis that MMP-9 is associated with BBB disruption. If the association between MMP-9 and BBB disruption is confirmed in future studies, HARM may be a useful imaging marker to evaluate MMP-9 inhibition in ischemic stroke and other populations with BBB disruption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Cited by
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Preclinical and clinical research on inflammation after intracerebral hemorrhage
Wang, J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.08.001 · Cited by 602
Acute Stroke Imaging Research Roadmap
Wintermark, M., Albers, G. W., Alexandrov, A. V., Alger, J. R., Bammer, R., Baron, J.-C., Davis, S., Demaerschalk, B. M., Derdeyn, C. P., Donnan, G. A., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.512319 · Cited by 423
Self-citationMatrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
Lakhan, S. E., Kirchgessner, A., Tepper, D., & Leonard, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00032 · Cited by 384
Acute Stroke Imaging Research Roadmap II
Wintermark, M., Albers, G. W., Broderick, J. P., Demchuk, A. M., Fiebach, J. B., Fiehler, J., Grotta, J. C., Houser, G., Jovin, T. G., Lees, K. R., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.002015 · Cited by 366
Self-citationGenomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling
Barr, T. L., Conley, Y., Ding, J., Dillman, A., Warach, S., Singleton, A., & Matarin, M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f2b37f · Cited by 264
Self-citationJin, R., Yang, G., & Li, G. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.008 · Cited by 252
Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy
Rempe, R. G., Hartz, A. M. S., Soldner, E. L. B., Sokola, B. S., Alluri, S. R., Abner, E. L., Kryscio, R. J., Pekcec, A., Schlichtiger, J., & Bauer, B. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2751-17.2018 · Cited by 162
Merino, J. G., & Warach, S. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.129 · Cited by 152
Self-citationImplicating endothelial cell senescence to dysfunction in the ageing and diseased brain
Graves, S. I., & Baker, D. J. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13403 · Cited by 118
Brain endothelial dysfunction in cerebral adrenoleukodystrophy
Musolino, P. L., Gong, Y., Snyder, J. M. T., Jimenez, S., Lok, J., Lo, E. H., Moser, A. B., Grabowski, E. F., Frosch, M. P., & Eichler, F. S. (2015) · Brain · doi:10.1093/brain/awv250 · Cited by 92
CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review
Freeze, W. M., van der Thiel, M., de Bresser, J., Klijn, C. J. M., van Etten, E. S., Jansen, J. F. A., van der Weerd, L., Jacobs, H. I. L., Backes, W. H., & van Veluw, S. J. (2020) · NeuroImage: Clinical · doi:10.1016/j.nicl.2020.102456 · Cited by 33
Blood brain barrier inflammation and potential therapeutic role of phytochemicals
Welcome, M. O. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100177 · Cited by 22
Dickerson, F., Vaidya, D., Liu, Y., & Yolken, R. (2023) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2023.02.007 · Cited by 18
“For example, several studies have documented that increased levels of MMP-9 are associated with alterations in the blood-brain barrier (48,49).”
Background
Metadata
- Authors
- Barr, T. L., Latour, L. L., Lee, K.-Y., Schaewe, T. J., Luby, M., Chang, G. S., El-Zammar, Z., Alam, S., Hallenbeck, J. M., Kidwell, C. S., & Warach, S.
- Venue
- Stroke
- Published
- 2010-03
- Volume
- 41
- Issue
- 3
- Pages
- e123-8
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2103114977
- Cited by
- 226
- References
- 1
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.